Insider trades
Michael Aaron Kelly, Director of Prime Medicine PRME, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/05.
Michael Aaron Kelly
Director
- Company
- Prime Medicine PRME
- First filing
- 23/05/10
- Trades
- 44 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NeogenomicsNEO | Open-market buy | 25/05/27 | 25/05/28 | 5,000 sh | $7.60 | $38,000 | No record |
